Articles by: Melville Contributor

Inside the Numbers for ASOS Plc (AIM:ASC)

Inside the Numbers for ASOS Plc (AIM:ASC)

November 29, 2017 at 9:21 am 0 comments

ASOS Plc (AIM:ASC) has a current EV or Enterprise Value of 5040006. The EV displays how the market assigns value to a firm as a whole. EV is generally a modification of market cap, as it incorporates debt and cash for assessing a firm’s valuation. Tracking EV may help whenRead More

Equity Sheet: Reviewing the Levels for Dufry AG (SWX:DUFN)

Equity Sheet: Reviewing the Levels for Dufry AG (SWX:DUFN)

November 29, 2017 at 9:20 am 0 comments

Dufry AG (SWX:DUFN) presently has an EV or Enterprise Value of 11815013. The EV helps show how the market assigns value to a company as a whole. EV is a modification of market cap, as it incorporates debt and cash for assessing a firm’s valuation. Watching a firm’s EV may beRead More

Company Spotlight on Shares of GKN plc (LSE:GKN)

Company Spotlight on Shares of GKN plc (LSE:GKN)

November 29, 2017 at 9:20 am 0 comments

GKN plc (LSE:GKN) has a current EV or Enterprise Value of 6581140. The EV displays how the market assigns value to a firm as a whole. EV is generally a modification of market cap, as it incorporates debt and cash for assessing a firm’s valuation. Tracking EV may help whenRead More

Equity Sheet: Reviewing the Levels for SYNNEX Corporation (NYSE:SNX)

Equity Sheet: Reviewing the Levels for SYNNEX Corporation (NYSE:SNX)

November 29, 2017 at 9:19 am 0 comments

SYNNEX Corporation (NYSE:SNX) has a current EV or Enterprise Value of 6549321. The EV displays how the market assigns value to a firm as a whole. EV is generally a modification of market cap, as it incorporates debt and cash for assessing a firm’s valuation. Tracking EV may help whenRead More

Looking at the Numbers for Agios Pharmaceuticals, Inc. (NasdaqGS:AGIO)

Looking at the Numbers for Agios Pharmaceuticals, Inc. (NasdaqGS:AGIO)

November 29, 2017 at 9:18 am 0 comments

Investors are constantly examining different company financial indicators to assess trading opportunities. Agios Pharmaceuticals, Inc. (NasdaqGS:AGIO) presently has an EV or Enterprise Value of 2643381. The EV is used to show how the market assigns value to a company as a whole. EV is basically a modification of market cap,Read More